Kacper Guglas

815 total citations
31 papers, 563 citations indexed

About

Kacper Guglas is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Kacper Guglas has authored 31 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 26 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Kacper Guglas's work include Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (18 papers) and Circular RNAs in diseases (14 papers). Kacper Guglas is often cited by papers focused on Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (18 papers) and Circular RNAs in diseases (14 papers). Kacper Guglas collaborates with scholars based in Poland, Netherlands and Brazil. Kacper Guglas's co-authors include Tomasz Kolenda, Katarzyna Lamperska, Anna Teresiak, Renata Bliźniak, Joanna Sobocińska, Andrzej Maćkiewicz, Jacek Mackiewicz, Jacek Mackiewicz, Urszula Kazimierczak and Iga Kołodziejczak and has published in prestigious journals such as International Journal of Molecular Sciences, Oncotarget and Cells.

In The Last Decade

Kacper Guglas

30 papers receiving 562 citations

Peers

Kacper Guglas
Kacper Guglas
Citations per year, relative to Kacper Guglas Kacper Guglas (= 1×) peers Tonghai Huang

Countries citing papers authored by Kacper Guglas

Since Specialization
Citations

This map shows the geographic impact of Kacper Guglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kacper Guglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kacper Guglas more than expected).

Fields of papers citing papers by Kacper Guglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kacper Guglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kacper Guglas. The network helps show where Kacper Guglas may publish in the future.

Co-authorship network of co-authors of Kacper Guglas

This figure shows the co-authorship network connecting the top 25 collaborators of Kacper Guglas. A scholar is included among the top collaborators of Kacper Guglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kacper Guglas. Kacper Guglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolenda, Tomasz, Kacper Guglas, Katarzyna Regulska, et al.. (2025). AURKAPS1, HERC2P2 and SDHAP1 pseudogenes: molecular role in development and progression of head and neck squamous cell carcinomas and their diagnostic utility. Reports of Practical Oncology & Radiotherapy. 29(6). 718–731.
2.
Kolenda, Tomasz, Kacper Guglas, Katarzyna Regulska, et al.. (2024). The RNA world: from experimental laboratory to "in silico" approach. Part 1: User friendly RNA expression databases portals. Reports of Practical Oncology & Radiotherapy. 5 indexed citations
3.
Kolenda, Tomasz, et al.. (2023). Biological role and diagnostic utility of ribosomal protein L23a pseudogene 53 in cutaneous melanoma. Reports of Practical Oncology & Radiotherapy. 28(2). 255–270. 8 indexed citations
4.
Guglas, Kacper, et al.. (2023). miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncology. Reports of Practical Oncology & Radiotherapy. 28(5). 681–697. 10 indexed citations
5.
Kolenda, Tomasz, Kacper Guglas, Anna Florczak, et al.. (2023). SRY-Related Transcription Factors in Head and Neck Squamous Cell Carcinomas: In Silico Based Analysis. Current Issues in Molecular Biology. 45(12). 9431–9449. 4 indexed citations
6.
Kolenda, Tomasz, et al.. (2023). Host gene and its guest: short story about relation of long-noncoding MIR31HG transcript and microRNA miR-31. Reports of Practical Oncology & Radiotherapy. 28(1). 114–134. 5 indexed citations
7.
Guglas, Kacper, Tomasz Kolenda, Patrícia Severino, et al.. (2023). The Impact of YRNAs on HNSCC and HPV Infection. Biomedicines. 11(3). 681–681. 5 indexed citations
8.
Regulska, Katarzyna, et al.. (2023). Angiotensin-converting enzyme inhibitors for ovarian cancer? — a new adjuvant option or a silent trap. Reports of Practical Oncology & Radiotherapy. 28(4). 551–564. 4 indexed citations
9.
Kolenda, Tomasz, Kacper Guglas, Joanna Sobocińska, et al.. (2020). Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck. Journal of Personalized Medicine. 10(3). 131–131. 7 indexed citations
10.
Kolenda, Tomasz, Kacper Guglas, Joanna Sobocińska, et al.. (2020). PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas. Diagnostics. 10(10). 762–762. 25 indexed citations
11.
Sobocińska, Joanna, Tomasz Kolenda, Anna Teresiak, et al.. (2020). Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome. Diagnostics. 10(10). 786–786. 15 indexed citations
12.
Guglas, Kacper, Iga Kołodziejczak, Tomasz Kolenda, et al.. (2020). YRNAs and YRNA-Derived Fragments as New Players in Cancer Research and Their Potential Role in Diagnostics. International Journal of Molecular Sciences. 21(16). 5682–5682. 32 indexed citations
13.
Guglas, Kacper, Tomasz Kolenda, Anna Teresiak, et al.. (2020). YRNAs: New Insights and Potential Novel Approach in Head and Neck Squamous Cell Carcinoma. Cells. 9(5). 1281–1281. 15 indexed citations
14.
Kolenda, Tomasz, Kacper Guglas, Joanna Sobocińska, et al.. (2020). Good or not good: Role of miR-18a in cancer biology. Reports of Practical Oncology & Radiotherapy. 25(5). 808–819. 65 indexed citations
15.
Kolenda, Tomasz, Kacper Guglas, Joanna Sobocińska, et al.. (2020). cfRNAs as biomarkers in oncology – still experimental or applied tool for personalized medicine already?. Reports of Practical Oncology & Radiotherapy. 25(5). 783–792. 25 indexed citations
16.
Kozłowska, Joanna, et al.. (2020). The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define. Współczesna Onkologia. 24(2). 96–105. 8 indexed citations
17.
Kolenda, Tomasz, Kacper Guglas, Anna Teresiak, Renata Bliźniak, & Katarzyna Lamperska. (2019). Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome. Journal of Biomedical Science. 26(1). 17–17. 16 indexed citations
18.
Kolenda, Tomasz, Kacper Guglas, Anna Teresiak, et al.. (2018). EGOT lncRNA in head and neck squamous cell carcinomas. Polish Journal of Pathology. 69(4). 356–365. 14 indexed citations
19.
Kolenda, Tomasz, Kacper Guglas, Anna Teresiak, et al.. (2017). Biological role of long non-coding RNA in head and neck cancers. Reports of Practical Oncology & Radiotherapy. 22(5). 378–388. 41 indexed citations
20.
Guglas, Kacper, Tomasz Kolenda, Anna Teresiak, et al.. (2017). lncRNA in HNSCC: challenges and potential. Współczesna Onkologia. 21(4). 259–266. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026